Levothyroxine sodium 0.1 MG Injection — RxCUI 1115267
RxNorm drug concept · Semantic clinical drug
RxCUI 1115267
Semantic clinical drug · SCD
● Current RxNorm concept 24 FDA products
24 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1115267
Official nameLevothyroxine sodium 0.1 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevothyroxine sodium 100 MCG Injection
FDA products mapped24
Package NDCs mapped24
Reported Medicaid activity (SDUD)490 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Levothyroxine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Your thyroid gland isn't making enough of a hormone called T4, which your whole body depends on to regulate your energy, metabolism, heart rate, and more. Levothyroxine is a precis...
- What exactly is levothyroxine doing for me — why do I need to take it every day?
- Timing really does make a difference with this medication. Food — especially high-fiber foods or anything soy-based — can block your gut from absorbing it properly. Taking it 30 to...
- Why does it matter so much when I take it — can't I just take it with breakfast?
🕸️ Concept Web — How Levothyroxine sodium 0.1 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Levothyroxine sodium 0.1 MG Injection
RxCUI 1115267 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Levothyroxine
10582IN -
Levothyroxine sodium
40144PIN
-
Levothyroxine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Levothyroxine Injection
1868004SCDF -
Levothyroxine sodium Injection
2647504SCDFP -
Levothyroxine Injectable Product
1602750SCDG -
Levothyroxine sodium Injectable Product
2662329SCDGP -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Levothyroxine Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Levothyroxine sodium 0.1 MG
892245SCDC
-
Levothyroxine sodium 0.1 MG
Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Levothyroxine sodium 0.1 MG
SCDC · 892245 -
Levothyroxine Injection
SCDF · 1868004 -
Levothyroxine sodium Injection
SCDFP · 2647504 -
Levothyroxine Injectable Product
SCDG · 1602750 -
Levothyroxine sodium Injectable Product
SCDGP · 2662329
📦 FDA Products & Package NDCs
24 products · 24 package NDCs
24 package NDCs map to RxCUI 1115267 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 25021-0468-10 | 1 VIAL in 1 CARTON (25021-468-10) / 5 mL in 1 VIAL | Levothyroxine Sodium | Sagent Pharmaceuticals | 2024-01-01 |
| 25021-0469-10 | 1 VIAL in 1 CARTON (25021-469-10) / 5 mL in 1 VIAL | Levothyroxine Sodium | Sagent Pharmaceuticals | 2024-01-01 |
| 25021-0470-10 | 1 VIAL in 1 CARTON (25021-470-10) / 5 mL in 1 VIAL | Levothyroxine Sodium | Sagent Pharmaceuticals | 2024-01-01 |
| 42023-0201-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-201-01) / 5 mL in 1... | Levothyroxine Sodium | ENDO USA, Inc. | 2011-06-24 |
| 42023-0202-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-202-01) / 5 mL in 1... | Levothyroxine Sodium | ENDO USA, Inc. | 2011-06-24 |
| 42023-0203-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (42023-203-01) / 5 mL in 1... | Levothyroxine Sodium | ENDO USA, Inc. | 2011-06-24 |
| 63323-0647-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-647-10) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 63323-0648-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-648-10) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 63323-0648-94 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-648-94) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 63323-0649-07 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-649-07) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 63323-0649-16 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-649-16) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 63323-0649-94 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-649-94) / 5 mL in 1... | Levothyroxine Sodium | Fresenius Kabi USA, LLC | 2011-06-24 |
| 66794-0200-02 | 5 mL in 1 VIAL, SINGLE-USE (66794-200-02) | Levothyroxine Sodium | Piramal Critical Care, Inc. | 2022-10-01 |
| 66794-0201-02 | 5 mL in 1 VIAL, SINGLE-USE (66794-201-02) | Levothyroxine Sodium | Piramal Critical Care, Inc. | 2022-10-01 |
| 70511-0111-10 | 1 VIAL, SINGLE-USE in 1 CARTON (70511-111-10) / 5 mL in 1 V... | Levothyroxine Sodium | MAIA Pharmaceuticals, Inc. | 2019-12-27 |
| 70511-0112-10 | 1 VIAL, SINGLE-USE in 1 CARTON (70511-112-10) / 5 mL in 1 V... | Levothyroxine Sodium | MAIA Pharmaceuticals, Inc. | 2018-12-27 |
| 70511-0113-10 | 1 VIAL, SINGLE-USE in 1 CARTON (70511-113-10) / 5 mL in 1 V... | Levothyroxine Sodium | MAIA Pharmaceuticals, Inc. | 2018-12-27 |
| 70710-1833-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1833-1) / 5 mL in 1... | LEVOTHYROXINE SODIUM | Zydus Pharmaceuticals USA Inc. | 2024-11-01 |
| 70710-1834-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1834-1) / 5 mL in 1... | LEVOTHYROXINE SODIUM | Zydus Pharmaceuticals USA Inc. | 2024-11-01 |
| 70710-1835-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (70710-1835-1) / 5 mL in 1... | LEVOTHYROXINE SODIUM | Zydus Pharmaceuticals USA Inc. | 2024-11-01 |
| 72266-0261-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72266-261-01) / 5 mL in 1... | Levothyroxine Sodium | Fosun Pharma USA Inc. | 2025-09-16 |
| 83270-0006-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83270-006-01) / 5 mL in 1... | Levothyroxine Sodium | ONESOURCE SPECIALTY PHARMA LIMITED | 2026-04-27 |
| 83270-0007-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83270-007-01) / 5 mL in 1... | Levothyroxine Sodium | ONESOURCE SPECIALTY PHARMA LIMITED | 2026-04-27 |
| 83270-0008-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (83270-008-01) / 5 mL in 1... | Levothyroxine Sodium | ONESOURCE SPECIALTY PHARMA LIMITED | 2026-04-27 |
Observed labelers:
Fresenius Kabi USA, LLC (6) ·
ENDO USA, Inc. (3) ·
MAIA Pharmaceuticals, Inc. (3) ·
ONESOURCE SPECIALTY PHARMA LIMITED (3) ·
Sagent Pharmaceuticals (3) ·
Zydus Pharmaceuticals USA Inc. (3)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0650 | Inj, levothyroxine nos 10mcg | 15 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.